Concepedia

Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors

Mei‐Zhen Wu, Chanchal Chandramouli, Pui‐Fai Wong, Yap‐Hang Chan, Hang‐Long Li, Si-Yeung Yu, Yi-Kei Tse, Q W Ren, Shuk-Yin Yu, Hung‐Fat Tse,

Diabetes & Metabolism · 2022 · 49 citations · 32 references

Open access

Concepts

Veterinary MedicinePharmacologyPharmacotherapyClinical PharmacologyInflammationSepsisClinical Recognition Of SepsisComplications Of SepsisPneumonia PharmacotherapySepsis ManagementSepsis PreventionSeptic ShockSepsis-associated Lung InjurySepsis-associated Respiratory FailureSevere Pneumonia Management

References

32

A Proportional Hazards Model for the Subdistribution of a Competing Risk

Jason P. Fine · Journal of the American Statistical Association · 1999 · 13.6K citations

Public Health, Biostatistics, Cost-effectiveness Analysis +15

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey et al. · New England Journal of Medicine · 2017 · 7.8K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

N.H. Cho, Jonathan E. Shaw, Suvi Karuranga et al. · Diabetes Research and Clinical Practice · 2018 · 7.4K citations

Medicine, Chronic Disease Prevention, Endocrinology +12

Dapagliflozin in Patients with Chronic Kidney Disease

Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter et al. · New England Journal of Medicine · 2020 · 5.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Covariate Balancing Propensity Score

Kosuke Imai, Marc Ratkovic · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 2013 · 1.3K citations

Public Health, Biostatistics, Causal Inference +16